TREMELIMUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 20:46:58 GMT 2025` Edited by `admin` on `Mon Mar 31 20:46:58 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG2
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	QEN1X95CIX
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

TREMELIMUMAB (GENETICAL RECOMBINATION)

Preferred Name

English

TREMELIMUMAB

Official Name

English

IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER

Common Name

English

CP-675206

Code

English

TREMELIMUMAB [JAN]

Common Name

English

TREMELIMUMAB (GENETICAL RECOMBINATION) [JAN]

Common Name

English

tremelimumab [INN]

Common Name

English

TREMELIMUMAB [USAN]

Common Name

English

PF-06753388

Code

English

IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULFIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER

Common Name

English

CP-675,206

Code

English

TICILIMUMAB

Common Name

English

Tremelimumab [WHO-DD]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

721419

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

FDA ORPHAN DRUG

227306

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

NCI_THESAURUS

C128036

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

FDA ORPHAN DRUG

466014

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

Code System Code Type Description

USAN

RR-51

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

SMS_ID

100000129086

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

DRUG BANK

DB11771

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

NCI_THESAURUS

C49085

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

FDA UNII

QEN1X95CIX

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

CAS

745013-59-6

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

RXCUI

2619313

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

DAILYMED

QEN1X95CIX

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

EVMPD

SUB37101

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

WIKIPEDIA

TREMELIMUMAB

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

ChEMBL

CHEMBL2108658

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

INN

8716

Created by admin on Mon Mar 31 20:46:58 GMT 2025 , Edited by admin on Mon Mar 31 20:46:58 GMT 2025

PRIMARY

From	To
1_22	1_96
1_139	3_214
1_152	1_208
1_227	2_227
1_228	2_228
1_231	2_231
1_234	2_234
1_265	1_325
1_371	1_429
2_22	2_96
2_139	4_214
2_152	2_208
2_265	2_325
2_371	2_429
3_23	3_88
3_134	3_194

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_301
N	2_301

Related Record Type Details


					KYU4T5WAI2

CYTOTOXIC T-LYMPHOCYTE PROTEIN 4

TARGET -> INHIBITOR

Tremelimumab-ACTL

SUB_CONCEPT->SUBSTANCE

Amount:

Related Record Type Details


					QEN1X95CIX

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:SEQUENCE	CHEMICAL